Yildiz, R. Et Al. 2010. Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens. Journal of Oncology Pharmacy Practice , vol.16, no.3 , 173-178.

Yildiz, R., Kalender, M. E., Dane, F., Sevinc, A., Gumus, M., Camci, C., ... Alici, S.(2010). Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens. Journal of Oncology Pharmacy Practice , vol.16, no.3, 173-178.

Yildiz, Ramazan Et Al. "Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens," Journal of Oncology Pharmacy Practice , vol.16, no.3, 173-178, 2010

Yildiz, Ramazan Et Al. "Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens." Journal of Oncology Pharmacy Practice , vol.16, no.3, pp.173-178, 2010

Yildiz, R. Et Al. (2010) . "Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens." Journal of Oncology Pharmacy Practice , vol.16, no.3, pp.173-178.

@article{article, author={Ramazan Yildiz Et Al. }, title={Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens}, journal={Journal of Oncology Pharmacy Practice}, year=2010, pages={173-178} }